Laman UtamaMNKD • NASDAQ
add
MannKind Corp
$4.74
Selepas Waktu Dagangan:(2.95%)-0.14
$4.60
Tutup: 25 Apr, 4:30:00 PTG GMT-4 · USD · NASDAQ · Penafian
Tutup sebelumnya
$4.67
Julat hari
$4.64 - $4.75
Julat tahun
$4.11 - $7.62
Permodalan pasaran
1.44B USD
Bilangan Purata
1.97J
Nisbah P/E
48.77
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Invezz
1 hari lalu
Amaran risiko: ‘kemelesetan sederhana’ boleh menjejaskan tahap S&P 500 kepada 3,700
0.74%
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Hasil | 76.78J | 31.30% |
Perbelanjaan pengendalian | 35.11J | 17.93% |
Pendapatan bersih | 7.42J | 429.76% |
Margin untung bersih | 9.67 | 302.92% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 24.22J | 104.25% |
Kadar cukai berkesan | 12.11% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 203.56J | -32.60% |
Jumlah aset | 393.84J | -17.12% |
Jumlah liabiliti | 472.66J | -34.48% |
Jumlah ekuiti | -78.82J | — |
Syer tertunggak | 303.59J | — |
Harga kepada buku | -17.96 | — |
Pulangan pada aset | 12.86% | — |
Pulangan pada modal | 52.03% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 7.42J | 429.76% |
Tunai daripada operasi | 22.64J | 4.46% |
Tunai daripada pelaburan | 48.22J | 710.82% |
Tunai daripada pembiayaan | -86.90J | -161.33% |
Perubahan bersih dalam tunai | -16.03J | -110.31% |
Aliran tunai bebas | 30.14J | 94.30% |
Perihal
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann. Wikipedia
Diasaskan
Feb 1991
Ibu pejabat
Tapak web
Pekerja
405
